What is NDC 66993-606?

66993-606 is the product NDC for Mirtazapine, Mirtazapine 7.5 mg/1 tablet, film coated, listed with the FDA by Prasco Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.

Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mirtazapine?

138 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mirtazapine NDC 66993-606 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)66993-606Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66993-0606Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66993-606-04	6699306060466993060604	500 TABLET, FILM COATED in 1 BOTTLE (66993-606-04)Marketed from Jun 1, 2023
66993-606-30	6699306063066993060630	30 TABLET, FILM COATED in 1 BOTTLE (66993-606-30)Marketed from Jun 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mirtazapine
Generic name (nonproprietary): mirtazapine
Active ingredients: Mirtazapine — 7.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Prasco LaboratoriesNDC labeler code 66993
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216751
Marketing start: Jun 1, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 66993-606_e1a19354-1c97-49ed-8ec9-bb895dbe69f3SPL ID e1a19354-1c97-49ed-8ec9-bb895dbe69f3SPL set ID 8b2a08f7-4803-42fa-a2b5-5ea51f8ef7e4RxCUI 311725, 311726, 314111, 476809UNII A051Q2099QUPC 0366993607306, 0366993607047, 0366993608044

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466993060604 followed by a unit qualifier and the quantity

Package 66993-0606-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 1, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ] . Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 66993-606

What is NDC 66993-606?: 66993-606 is the product NDC for Mirtazapine, Mirtazapine 7.5 mg/1 tablet, film coated, listed with the FDA by Prasco Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mirtazapine.
What is the active ingredient?: Mirtazapine.
Who is the labeler?: Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mirtazapine?: 138 other product NDCs are listed under this name. See all Mirtazapine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mirtazapine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0319	67046-0319-03
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-0280	55154-0280-00
Mirtazapine	Mirtazapine 7.5 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0625	67046-0625-03
Mirtazapine	Mirtazapine 45 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-2024	67046-2024-03
Mirtazapine	Mirtazapine 7.5 mg/1	Tablet, Film coatedOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8663	00615-8663-0500615-8663-39
Mirtazapine	Mirtazapine 7.5 mg/1	Tablet, Film coatedOral	ANI Pharmaceuticals, Inc.	70954-830	70954-0830-10
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0484	67046-0484-03
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0068	67046-0068-03
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-077	48433-0077-20
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-076	48433-0076-20

All 139 Mirtazapine NDCs

Other NDCs under ANDA 216751

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216751
Product	Strength	Form · route	Labeler	Product NDC
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Prasco Laboratories	66993-607
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Prasco Laboratories	66993-608
Mirtazapine	Mirtazapine 45 mg/1	Tablet, Film coatedOral	Prasco Laboratories	66993-609
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Aphena Pharma Solutions - Tennessee, LLC	71610-846
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Aphena Pharma Solutions - Tennessee, LLC	71610-853